Announcements Trials
Browse Landscape

Status

Completed 4Unknown 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 65Observational 4

Sponsor

Cancer Type

Plasma cell 4Genitourinary 1

Conditions

Multiple Myeloma 4Personal Satisfaction 1Patient Satisfaction 1Patient Preference 1Acute Kidney Injury 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Observational × daratumumab × Clear all
NCT06549634 2026-02-27

Biomarkers of AKI in Patients Receiving Daratumumab

Brigham and Women's Hospital

Completed
20 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT05835726 2025-08-15

DILEMMA

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Completed
188 enrolled
Plasma cell

Multiple Myeloma

NCT05284591 2024-10-01

MYLENE

iOMEDICO AG

Completed
96 enrolled
Plasma cell

Multiple Myeloma, Personal Satisfaction, Patient Satisfaction, Patient Preference

NCT05306587 2024-04-03

Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project.

Odense University Hospital

Completed
40 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡